Retro Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 14

Retro General Information

Description

Developer of age-related therapeutics designed to extend healthy human lifespan by targeting the biological mechanisms of aging. The company offers a platform that integrates single-cell multi-omics, pooled perturbation screening, and targeted delivery technologies, enabling biopharmaceutical developers to prevent and reverse age-related diseases through accelerated translation of aging reversal mechanisms into human therapies.

Contact Information

Website
www.retro.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2021 Fillmore Street
  • Suite 70
  • San Francisco, CA 94115
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2021 Fillmore Street
  • Suite 70
  • San Francisco, CA 94115
  • United States

Retro Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Retro Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Clinical Trials - Phase 1
3. Later Stage VC (Series A) 22-May-2026 Completed Clinical Trials - Phase 1
2. Later Stage VC (Series A) 18-Sep-2025 $1B $1.18B Completed Pre-Clinical Trials
1. Angel (individual) 06-Apr-2022 $180M $180M Completed Pre-Clinical Trials
To view Retro’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Retro Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Retro Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
4P Capital Venture Capital Minority
Inventive Capital ( Family Office) Family Office Minority
Samudra Pacific Capital Partners Venture Capital Minority
Small World Capital Venture Capital Minority
SparkLabs Group Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Retro FAQs

  • When was Retro founded?

    Retro was founded in 2020.

  • Where is Retro headquartered?

    Retro is headquartered in San Francisco, CA.

  • What is the size of Retro?

    Retro has 100 total employees.

  • What industry is Retro in?

    Retro’s primary industry is Drug Discovery.

  • Is Retro a private or public company?

    Retro is a Private company.

  • What is Retro’s current revenue?

    The current revenue for Retro is .

  • How much funding has Retro raised over time?

    Retro has raised $1.18B.

  • Who are Retro’s investors?

    4P Capital, Inventive Capital ( Family Office), Samudra Pacific Capital Partners, Small World Capital, and SparkLabs Group are 5 of 14 investors who have invested in Retro.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process